| Literature DB >> 34011707 |
Javed Hussain Farooqui1, Umang Mathur1, Rashmi Rani Pahwa2, Aditi Singh2, Vaishali Vasavada3, Reena M Chaudhary4.
Abstract
Purpose: To assess the outcome of 2 weeks phacoemulsification training program that is a unique collaboration between premier ophthalmic training institutes of India and Alcon Inc. initiated 10 years ago.Entities:
Keywords: Cataract; phacoemulsification; training
Mesh:
Year: 2021 PMID: 34011707 PMCID: PMC8302294 DOI: 10.4103/ijo.IJO_2785_20
Source DB: PubMed Journal: Indian J Ophthalmol ISSN: 0301-4738 Impact factor: 1.848
Two-week training schedule for the participants
| Phaco Development Program (PDP) 2 Weeks Schedule | ||
|---|---|---|
| Time | Agenda | Concerned Person |
| Day 1-Monday | ||
| 09:00 AM-10:00 AM | Course Introduction | PDS |
| 10:00 AM-11:00 AM | Hospital Introduction | Administrator |
| 11:00 AM-01:00 PM | OR& System Orientation | PDS& Admin |
| 01:00 PM-02:00 PM | Lunch | Canteen |
| 02:00 PM-03:00 PM | Wet lab-Incision, CCC & Hydro procedure | PDS |
| 03:00 PM-04:30 PM | Lecture-Proper Patient Selection | Consultant |
| Day 2-Tuesday | ||
| 08:00 AM-08:30 AM | Post Op Rounds | Participant & Trainer |
| 08:30 AM-12:30 PM | OR - Incision, CCC& Hydro procedure* | Consultant |
| 01:00 PM-02:00 PM | Lunch | Canteen |
| 02:00 PM-03:00 PM | Wet lab-Incision, CCC & Hydro procedure | PDS |
| 03:00 PM-04:30 PM | Lecture-Incision, CCC & Hydro | Consultant |
| 04:30 PM-05:00 PM | OR Case Review | Consultant |
| Day 3-Wednesday | ||
| 08:00 AM-08:30 AM | Post Op Rounds | Participant & Trainer |
| 08:30 AM-12:30 PM | OR-Incision, CCC & Hydro procedure* | Consultant |
| 01:00 PM-02:00 PM | Lunch | Canteen |
| 02:00 PM-03:00 PM | Wet lab-Trenching & Cracking | PDS |
| 03:00 PM-04:30 PM | Lecture-Nucleus Management | Consultant |
| 04:30 PM-05:00 PM | OR Case Review | Consultant |
| Day 4-Thursday | ||
| 08:00 AM-08:30 AM | Post Op Rounds | Participant & Trainer |
| 08:30 AM-12:30 PM | OR-Trenching & Cracking* | Consultant |
| 01:00 PM-02:00 PM | Lunch | Canteen |
| 02:00 PM-03:00 PM | Wet lab - Trenching & Cracking | PDS |
| 03:00 PM-04:30 PM | Lecture-Phaco Dynamics | PDS |
| 04:30 PM-05:00 PM | OR Case Review | Consultant |
| Day 5-Friday | ||
| 08:00 AM-08:30 AM | Post Op Rounds | Participant & Trainer |
| 08:30 AM-12:30 PM | OR-Trenching & Cracking* | Consultant |
| 01:00 PM-02:00 PM | Lunch | Canteen |
| 02:00 PM-03:00 PM | Wet lab - Nucleus Management | PDS |
| 03:00 PM-04:30 PM | Hands on: Machine Orientation | PDS |
| 04:30 PM-05:00 PM | OR Case Review | Consultant |
| Day 6-Saturday | ||
| 08:00 AM-08:30 AM | Post Op Rounds | Participant & Trainer |
| 08:30 AM-12:30 PM | OR-Nucleus Management* | Consultant |
| 01:00 PM-02:00 PM | Lunch | Canteen |
| 02:00 PM-03:00 PM | Wet lab- Complete Phacoemulsification Surgery | PDS |
| 03:00 PM-04:30 PM | Lecture-Ophthalmic Viscosurgical Devise | Consultant |
| 04:30 PM-05:00 PM | OR Case Review | Consultant |
| Sunday | ||
| Day 7-Monday | ||
| 08:00 AM-08:30 AM | Post Op Rounds | Participant & Trainer |
| 08:30 AM-12:30 PM | OR-Complete Phacoemulsification surgery | Consultant |
| 01:00 PM-02:00 PM | Lunch | Canteen |
| 02:00 PM-03:00 PM | Wet lab - Management of PCR& Anterior Vitrectomy | PDS |
| 03:00 PM-04:30 PM | Lecture-PCR Management & Anterior Vitrectomy Principles | Consultant |
| 04:30 PM-05:00 PM | OR Case Review | Consultant |
| Day 8-Tuesday | ||
| 08:00 AM-08:30 AM | Post Op Rounds | Participant & Trainer |
| 08:30 AM-12:30 PM | OR-Complete Phacoemulsification surgery | Consultant |
| 01:00 PM-02:00 PM | Lunch | Canteen |
| 02:00 PM-03:00 PM | Wet lab- Complete Nucleus Management | PDS |
| 03:00 PM-04:30 PM | Lecture-IOL (Various Types & Implantation Pearls) | Consultant |
| 04:30 PM-05:00 PM | OR Case Review | Consultant |
| Day 9-Wednesday | ||
| 08:00 AM-08:30 AM | Post Op Rounds | Participant & Trainer |
| 08:30 AM-12:30 PM | OR-Complete Phacoemulsification surgery | Consultant |
| 01:00 PM-02:00 PM | Lunch | Canteen |
| 02:00 PM-03:00 PM | Wet lab- Complete Nucleus Management | PDS |
| 03:00 PM-04:30 PM | Lecture-IOL Formula & Biometry | Consultant |
| 04:30 PM-05:00 PM | OR Case Review | Consultant |
| Day 10-Thursday | ||
| 08:00 AM-08:30 AM | Post Op Rounds | Participant & Trainer |
| 08:30 AM-12:30 PM | OR-Complete Phacoemulsification surgery | Consultant |
| 01:00 PM-02:00 PM | Lunch | Canteen |
| 02:00 PM-03:00 PM | Wet lab- Complete Nucleus Management | PDS |
| 03:00 PM-04:30 PM | Lecture-Complications Overview | Consultant |
| 04:30 PM-05:00 PM | OR Case Review | Consultant |
| Day 11 -Friday | ||
| 08:00 AM-08:30 AM | Post Op Rounds | Participant & Trainer |
| 08:30 AM-12:30 PM | OR-Complete Phacoemulsification surgery | Consultant |
| 01:00 PM-02:00 PM | Lunch | Canteen |
| 02:00 PM-03:00 PM | Wet lab- Complete Nucleus Management | PDS |
| 03:00 PM-04:30 PM | Queries & Doubts Clarification | Consultant and Participant |
| Day 12 - Saturday | ||
| 08:00 AM-08:30 AM | Post Op Rounds | Participant & Trainer |
| 08:30 AM-12:30 PM | OR-Complete Phacoemulsification surgery | Consultant |
| 01:00 PM-02:00 PM | Lunch | Canteen |
| 02:00 PM-03:00 PM | Wet lab- Complete Nucleus Management | PDS |
| 03:00 PM-04:30 PM | Queries Clarification & Feedback Session | Consultant and Participant |
PDS- Phaco Development Specialist, PDP- Phaco Development Program, OR- Operating Room, CCC- Continuous Curvilinear Capsulorhexis, Phaco- Phacoemulsification, IOL- Intra Ocular Lens. *Complete phaco case can be given depending upon the expertise of the participant & faculty discretion
Figure 1(a) Various participating institutes hosting trainees for Phaco Development Program (map of India, for representation only and not to scale; Developed in-house by co-author RRP) (b)Various states and Union Territories of India and number of participating candidates from each state (in brackets) (map of India, for representation only and not to scale; Developed in- house by co-author RRP)
Figure 2(a)Total number of phacoemulsification surgeries performed every year till August 2019; x Axis- years, y Axis- Number of surgeries (b)Distribution of number of phacoemulsification surgeries by participants trained from different training centers
Baseline characteristics of participants at various training centers
| Characteristics | Hospital 5 | Hospital 6 | Hospital 1 | Hospital 7 | Hospital 2 | Hospital 4 | Hospital 3 | Total |
|---|---|---|---|---|---|---|---|---|
| Number of Participants | 135 | 4 | 116 | 130 | 179 | 102 | 323 | 989 |
| Number of Phacoemulsification | 169,927 | 2171 | 132,130 | 137,247 | 121,641 | 54,521 | 404,871 | 1,022,508 |
| performed till August 2019 | ||||||||
| Type of surgery performed by the participant before joining the program | ||||||||
| Pure SICS | 76 (56.30%) | 2 (50%) | 70 (60.34%) | 37 (28.46%) | 109 (60.89%) | 64 (62.75%) | 193 (59.75%) | 551 (55.71%) |
| <30% Phaco | 26 (19.26%) | 0 (0%) | 20 (17.24%) | 38 (29.23%) | 24 (13.41%) | 14 (13.73%) | 62 (19.20%) | 184(18.60%) |
| 30% to 50%Phaco | 19 (14.07%) | 0 (0%) | 8 (6.90%) | 20 (15.38%) | 22 (12.29%) | 12 (11.76%) | 43 (13.31%) | 124 (12.54%) |
| 50% to 70% Phaco | 5 (3.70%) | 1 (25%) | 8 (6.90%) | 8 (6.15%) | 11 (6.15%) | 6 (5.88%) | 6 (1.86%) | 45 (4.55%) |
| >70% Phaco | 9 (6.67%) | 1 (25%) | 10 (8.62%) | 27 (20.77%) | 13 (7.26%) | 6 (5.88%) | 19 (5.88%) | 85 (8.59%) |
| Age at the time of enrollment (in years) | ||||||||
| 21-30 | 11 (8.15%) | 0 (0%) | 3 (2.59%) | 22 (16.92%) | 10 (5.59%) | 5 (4.90%) | 10 (3.10%) | 61 (6.17%) |
| 31-40 | 70 (51.85%) | 3 (75%) | 66 (56.90%) | 68 (52.31%) | 103 (57.54%) | 69 (67.65%) | 139 (43.03%) | 518 (52.38%) |
| 41-50 | 36 (26.67%) | 1 (25%) | 33 (28.45%) | 25 (19.23%) | 49 (27.37%) | 18 (17.65%) | 115 (35.60%) | 277 (28.01%) |
| 51-60 | 17 (12.59%) | 0 (0%) | 9 (7.76%) | 11 (8.46%) | 14 (7.82%) | 8 (7.84%) | 50 (15.48%) | 109 (11.02%) |
| >60 | 1 (0.74%) | 0 (0%) | 5 (4.31%) | 4 (3.08%) | 3 (1.68%) | 2 (1.96%) | 9 (2.79%) | 24 (2.43%) |
| Mean±SD | 40.34±7.98 | 40±7.26 | 40.87±8.14 | 38.52±8.89 | 39.79±7.48 | 38.84±7.54 | 42.55±8.28 | 40.63±8.2 |
| Gender | ||||||||
| Female | 44 (32.59%) | 2 (50%) | 35 (30.17%) | 61 (46.92%) | 83 (46.37%) | 34 (33.33%) | 89 (27.55%) | 348 (35.19%) |
| Male | 91 (67.41%) | 2 (50%) | 81 (69.83%) | 69 (53.08%) | 96 (53.63%) | 68 (66.67%) | 234 (72.45%) | 641 (64.81%) |
| Type of Institution | ||||||||
| GH | 20 (14.81%) | 0 (0%) | 14 (12.07%) | 4 (3.08%) | 38 (21.23%) | 11 (10.78%) | 29 (8.98%) | 116 (11.73%) |
| Individual | 70 (51.85%) | 2 (50%) | 49 (42.24%) | 93 (71.54%) | 85 (47.49%) | 60 (58.82%) | 142 (43.96%) | 501 (50.66%) |
| NGO | 1 (0.74%) | 0 (0%) | 18 (15.52%) | 1 (0.77%) | 8 (4.47%) | 6 (5.88%) | 18 (5.57%) | 52 (5.26%) |
| PEH | 44 (32.59%) | 2 (50%) | 35 (30.17%) | 32 (24.62%) | 48 (26.82%) | 25 (24.51%) | 134 (41.49%) | 320 (32.36%) |
| Years of follow-up | ||||||||
| Mean±SD | 4.09±2.26 | 2.5±1.73 | 4.93±2.59 | 5.12±2.37 | 3.58±1.78 | 2.17±1.24 | 5.1±2.41 | 4.36±2.4 |
SICS- Small Incision Cataract Surgery, Phaco- Phacoemulsification. GH- Government Hospital; NGO- Non Government Hospital; PEH- Private Eye Hospital; SD- Standard Deviation
Doctors in various age groups and hospitals performing Phacoemulsification at 1-year follow-up and at final follow-up (August 2019)
| Characteristics | Participants performing phacoemulsification at end of 1 year TOTAL-911 (92.11%) | Participants not performing phacoemulsification at end of 1 year Total-78 (7.89%) | Participants performing phacoemulsification at final follow-up TOTAL 878 (88.78%) | Participants not performing phacoemulsification at final follow-up Total-111 (11.22%) | ||
|---|---|---|---|---|---|---|
| Age in years | ||||||
| 21-30 ( | 57 (93.44%) | 4 (6.56%) | 0.84 | 57 (93.44%) | 4 (6.56%) | 0.082 |
| 31-40 ( | 480 (92.66%) | 38 (7.34%) | 464 (89.58%) | 54 (10.42%) | ||
| 41-50 ( | 254 (91.70%) | 23 (8.30%) | 248 (89.53%) | 29 (10.47%) | ||
| 51-60 ( | 99 (90.83%) | 10 (9.17%) | 90 (82.57%) | 19 (17.43%) | ||
| >60 ( | 21 (87.50%) | 3 (12.50%) | 19 (79.17%) | 5 (20.83%) | ||
| Type of Institution | 0.50 | 0.033 | ||||
| GH ( | 109 (93.97%) | 7 (6.03%) | 104 (89.66%) | 12 (10.34%) | ||
| Individual ( | 461 (92.02%) | 40 (7.98%) | 454 (90.62%) | 47 (9.38%) | ||
| NGO ( | 50 (96.15%) | 2 (3.85%) | 49 (94.23%) | 3 (5.77%) | ||
| PEH ( | 291 (90.94%) | 29 (9.06%) | 271 (84.69%) | 49 (15.31%) | ||
| Total | 911 (92.11%) | 78 (7.89%) | 878 (88.78%) | 111 (11.22%) |
* Comparing different age groups & between different types of institutions. GH- Government Hospital; NGO- Non Government Hospital; PEH- Private Eye Hospital; SD- Standard Deviation
Doctors performing Phacoemulsification at 1-year follow-up and at final follow-up (August 2019) compared to the type of surgery performed by them before joining PDP
| Type of surgeries performed by the participant before joining PDP | Participants performing phacoemulsification at end of 1 year Total 911 | Participants not performing phacoemulsification at end of 1 year Total 78 | Participants performing phacoemulsification at end of final follow-up Total-878 | Participants not performing phacoemulsification at end of final follow-up Total-111 | ||
|---|---|---|---|---|---|---|
| Pure SICS | 501 (90.93%) | 50 (9.07%) | 0.27 | 476 (86.39%) | 75 (13.61%) | 0.05 |
| <30% Phaco | 169 (91.85%) | 15 (8.15%) | 167 (90.76%) | 17 (9.24%) | ||
| 30%-50% Phaco | 116 (93.55%) | 8 (6.45%) | 112 (90.32%) | 12 (9.68%) | ||
| 50%-70% Phaco | 42 (93.33%) | 3 (6.67%) | 41 (91.11%) | 4 (8.89%) | ||
| >70% Phaco | 83 (97.65%) | 2 (2.35%) | 82 (96.47%) | 3 (3.53%) |
*Comparing different categories of surgeons. PDP- Phaco Development Program, SICS- Small Incision Cataract Surgery, Phaco- Phacoemulsification